Get started
Author

Whelton A. Miller

Observed names: Miller III, Whelton A Miller, Whelton A. Miller III, Whelton Miller
Observed institutions: University of the Sciences, Loyola University Medical Center, University of Ghana, Loyola University Chicago, Lincoln University - Pennsylvania, Loyola Medicine, University of Pennsylvania
ORCID: 0000-0003-3822-7940
Observed ORCID: 0000-0003-3822-7940
OpenAlex ID: A5081692917
In Silico Screening of Isocitrate Lyase for Novel Anti-Buruli Ulcer Natural Products Originating from Africa
2018 · Samuel K. Kwofie, Bismark Dankwa, et al. · Molecules · 54
PDF
Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24
2019 · Samuel K. Kwofie, Emmanuel Broni, et al. · Computers in Biology and Medicine · 48
A Molecular Modeling Approach to Identify Potential Antileishmanial Compounds Against the Cell Division Cycle (cdc)-2-Related Kinase 12 (CRK12) Receptor of Leishmania donovani
2021 · Emmanuel Broni, Samuel K. Kwofie, et al. · Biomolecules · 36
PDF
The Search for Putative Hits in Combating Leishmaniasis: The Contributions of Natural Products Over the Last Decade
2021 · Patrick O. Sakyi, Richard K. Amewu, et al. · Natural Products and Bioprospecting · 35
PDF
Identifying potential monkeypox virus inhibitors: an in silico study targeting the A42R protein
2024 · Carolyn N. Ashley, Emmanuel Broni, et al. · Frontiers in Cellular and Infection Microbiology · 32
PDF
Molecular Docking Simulation Studies Identifies Potential Natural Product Derived-Antiwolbachial Compounds as Filaricides against Onchocerciasis
2021 · Samuel Kwofie, Emmanuel Broni, et al. · Biomedicines · 31
PDF
Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
2023 · Emmanuel Broni, Carolyn Ashley, et al. · International Journal of Molecular Sciences · 28
PDF
Molecular Docking and Dynamics Simulation Studies Predict Potential Anti-ADAR2 Inhibitors: Implications for the Treatment of Cancer, Neurological, Immunological and Infectious Diseases
2023 · Emmanuel Broni, Andrew Striegel, et al. · International Journal of Molecular Sciences · 27
PDF
ADAR Family Proteins: A Structural Review
2024 · Carolyn N. Ashley, Emmanuel Broni, et al. · Current Issues in Molecular Biology · 26
Antiplasmodial activity of hydroxyethylamine analogs: Synthesis, biological activity and structure activity relationship of plasmepsin inhibitors
2018 · Amit Kumar Singh, Vinoth Rajendran, et al. · Bioorganic & Medicinal Chemistry · 23
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling
2023 · Patrick O. Sakyi, Samuel K. Kwofie, et al. · Pharmaceuticals · 20
PDF
Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase
2022 · Patrick O. Sakyi, Emmanuel Broni, et al. · Frontiers in Cellular and Infection Microbiology · 18
Molecular modelling and de novo fragment-based design of potential inhibitors of beta-tubulin gene of Necator americanus from natural products
2021 · Odame Agyapong, Seth O. Asiedu, et al. · Informatics in Medicine Unlocked · 18
PDF
Outwitting an Old Neglected Nemesis: A Review on Leveraging Integrated Data-Driven Approaches to Aid in Unraveling of Leishmanicides of Therapeutic Potential
2020 · Samuel K. Kwofie, Emmanuel Broni, et al. · Current Topics in Medicinal Chemistry · 17
Molecular Informatics Studies of the Iron-Dependent Regulator (ideR) Reveal Potential Novel Anti-Mycobacterium ulcerans Natural Product-Derived Compounds
2019 · Samuel K. Kwofie, Kweku S. Enninful, et al. · Molecules · 14
PDF
Natural Product Identification and Molecular Docking Studies of Leishmania Major Pteridine Reductase Inhibitors
2024 · Moses N. Arthur, George Hanson, et al. · Pharmaceuticals · 11
PDF
Design of Inhibitors That Target the Menin–Mixed-Lineage Leukemia Interaction
2023 · Moses N. Arthur, Kristeen Bebla, et al. · Computation · 11
PDF
Review of Atypical Organometallic Compounds as Antimalarial Drugs
2020 · Samuel K. Kwofie, Emmanuel Broni, et al. · Journal of Chemistry · 11
PDF
Antimalarials: Review of Plasmepsins as Drug Targets and HIV Protease Inhibitors Interactions
2018 · Whelton A. Miller III, Joshua Teye, et al. · Current Topics in Medicinal Chemistry · 11
Molecular docking and dynamics simulations studies of OmpATb identifies four potential novel natural product-derived anti-Mycobacterium tuberculosis compounds
2020 · Samuel K. Kwofie, Courage Adobor, et al. · Computers in Biology and Medicine · 10
In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds
2023 · Emmanuel Broni, Carolyn Ashley, et al. · International Journal of Molecular Sciences · 8
PDF
Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies
2023 · Patrick O. Sakyi, Emmanuel Broni, et al. · Informatics in Medicine Unlocked · 8
Unravelling the myth surrounding sterol biosynthesis as plausible target for drug design against leishmaniasis
2021 · Patrick O. Sakyi, Richard K. Amewu, et al. · Journal of Parasitic Diseases · 8
Pharmacophore-Guided Identification of Natural Products as Potential Inhibitors of Mycobacterium ulcerans Cystathionine γ-Synthase MetB
2021 · Samuel K. Kwofie, Nigel N. O. Dolling, et al. · Computation · 8
PDF
Development of a proteochemometric-based support vector machine model for predicting bioactive molecules of tubulin receptors
2021 · Odame Agyapong, Whelton A. Miller, et al. · Molecular Diversity · 7
Works count: 43
Citation count: 556
H-index: 14
I10-index: 20
Year
Topic
Type